Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma

Figure 1

Study design of the workflow. Flowchart showing the detailed process of how the circulating exosomal miR-101 and miR-125b panel was selected and validated in HCC.